EP3310760
CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLO-PENTA[B]INDOL-3-YL)ACETIC ACID FOR USE IN S1P1 RECEPTOR-ASSOCIATED DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.6.2016EP published:
14.9.2022EP application number:
16734529.7
EPO information:
European Patent Register
Max expiry date:
20.6.2036
Title in English:
CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLO-PENTA[B]INDOL-3-YL)ACETIC ACID FOR USE IN S1P1 RECEPTOR-ASSOCIATED DISORDERSLanguage of the patent:
English
Timeline
Today
21.6.2016EP application
14.9.2022EP Publication
Owner
Name:
Arena Pharmaceuticals, Inc.Address:
6154 Nancy Ridge Drive, San Diego, CA 92121, US
Inventor
Name:
BLACKBURN, Anthony C.Address:
San Diego, California 92128, US
Name:
CASTRO, Ryan O.Address:
San Diego, California 92129, US
Name:
HADD, Mark A.Address:
San Diego, California 92126, US
Name:
MA, You-AnAddress:
Poway, California 92064, US
Name:
MONTALBAN, Antonio GarridoAddress:
San Diego, California 92129, US
Name:
RUETER, Jaimie KarynAddress:
San Diego, California 92129, US
Name:
SELVEY, Lee AlaniAddress:
Poway, California 92064, US
Name:
SHAKYA, Sagar RajAddress:
San Diego, California 92129, US
Name:
CARLOS, MarlonAddress:
Chula Vista, California 91913, US
Priority
Number:
201562182841 PDate:
22.6.2015Country:
US
Number:
201562207531 PDate:
20.8.2015Country:
US
Classification
Categories:
C07D 209/94, A61K 31/403, A61P 37/00, A61P 29/00, A61P 35/00, A61P 9/00, A61P 1/00, A61P 7/00, A61P 3/00, A61P 5/00